Skip to content
Menu

BMO Capital Maintains Outperform on Ingevity, Lowers Price Target to $72

Benzinga Newsdesk 1 day ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

BMO Capital analyst John McNulty maintains Ingevity (NYSE:NGVT) with a Outperform and lowers the price target from $85 to $72.

BMO Capital analyst John McNulty maintains Ingevity (NYSE:NGVT) with a Outperform and lowers the price target from $85 to $72.

Read at benzinga.com

← All stock news